SUPPRESSION OF RENIN-ANGIOTENSIN SYSTEM TO PREVENT COMPLICATIONS OF CARDIOVASCULAR DISEASES: CURRENT 'ROLES' DISTRIBUTION FROM CLINICAL PHARMACOLOGIST’S POINT OF VIEW

Autor:	S. R. Gilyarevskiy, V. A. Orlov, M. V. Golshmid, G. Yu. Zakharova, I. I. Sinitsina
Jazyk:	English<br />Russian
Rok vydání:	2016
Předmět:	ингибитор ангиотензин-превращающего фермента профилактика сердечно-сосудистые заболевания периндоприл рамиприл трандолаприл Therapeutics. Pharmacology RM1-950 Diseases of the circulatory (Cardiovascular) system RC666-701
Zdroj:	Рациональная фармакотерапия в кардиологии, Vol 7, Iss 1, Pp 70-74 (2016)
Druh dokumentu:	article
ISSN:	1819-6446 2225-3653
DOI:	10.1234/1819-6446-2011-1-70-74
Popis:	A role of angiotensin-converting enzyme (ACE) inhibitors in cardiovascular diseases treatment and prevention is discussed. Some large randomized clinical trials are analyzed. Physical and chemical properties of drugs and its evidence base are considered among possible factors of ACE inhibitors choice. A problem of ACE inhibitor choice is also discussed in context of secondary prevention of cardiovascular complications in arterial hypertension and after myocardial infarction. It is concluded that the choice of any drug for cardiovascular disease treatment is mainly determined by its evidence base.
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/202a0deff3964600ba248e12f11854c4 Zobrazit plný text záznamu View record in DOAJ